Patent Law Weblog
recent posts
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
- United States Files Statement of Interest in Patent Infringement Proceedings
about
Month: January 2010
-
By Donald Zuhn — Last Thursday, the Federal Circuit determined in Wyeth v. Kappos that the U.S. Patent and Trademark Office had erred in making PTA calculations for two patents owned by Wyeth and Elan Pharma International Ltd. (see Patent Docs report). Since the appellate court rendered its decision, many patent practitioners and applicants…
-
By Sarah Fendrick — The U.S. Patent and Trademark Office has created a PCT task force to explore methods for improving the Office's role as a Receiving Office, an International Searching Authority (ISA), and an International Preliminary Examination Authority (IPEA). To support the newly created task force, a public meeting is being held on…
-
What Does It Tell Us About the Relationship between the Court and the Agency? By Kevin E. Noonan — The Federal Circuit last week affirmed the D.C. District Court's decision contradicting the Patent Office interpretation of 35 U.S.C. § 1.54(b) regarding patent term adjustment (see Patent Docs report). This decision is worthy of some…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Genzyme Corp. v. Cobrek Pharmaceuticals, Inc.1:10-cv-00112; filed January 7, 2009 in the Northern District of Illinois Infringement of U.S. Patent Nos. 5,602,116 ("Method…
-
January 20-21, 2010 – Life Sciences IP Due Diligence (American Conference Institute) – New York, NY January 25-26, 2010 – European Pharmaceutical Regulatory Law Boot Camp (American Conference Institute) – New York, NY January 26-27, 2010 – Advanced In-House Counsel Forum on China IP Law (C5) – Shanghai, China January 27-30, 2010 – Mid-Winter Institute…
-
Practising Law Institute (PLI) will be holding its 4th Annual Patent Law Institute on March 1-2, 2010 in New York, NY and on March 22-23, 2010 in San Francisco, CA. A live webcast of the San Francisco session will also be available. The two-day conference consists of six one-hour plenary sessions of broad interest to…
-
IIR will be holding its 18th annual Biotech & Pharmaceutical Patenting conference from February 17-18, 2010 in Munich, Germany. The conference will allow attendees to: • Prepare for upcoming changes with updates directly from the decision-makers at key patent offices;• Examine the effect of recent case law on patent term extensions and paediatric data exclusivity;•…
-
By Donald Zuhn — In a decision that will significantly impact the amount of patent term adjustment ("PTA") that many patentees can expect to obtain under U.S. Patent Law, the Court of Appeals for the Federal Circuit determined today that the U.S. Patent and Trademark Office had erred in making PTA calculations for two patents owned by Plaintiffs-Appellees Wyeth…
-
By James DeGiulio — A recent study published in The Columbia Science and Technology Law Review challenges the traditional view that patents foster innovation, suggesting instead that patents may harm creation of new technology, economic activity, and societal wealth ("Patents and the Regress of Useful Arts"). The study, conducted by Dr. Andrew W. Torrance…
-
By Suresh Pillai — The Medicines Company Files New Lawsuits in Angiomax® Patent Dispute Following up on lawsuits filed in October against defendant Teva Pharmaceuticals, The Medicines Company has now filed new lawsuits alleging infringement of U.S. Patent No. 7,598,343, which covers The Medicines Company's blood thinning drug, Angiomax®. In its original suit, The…
Patent Docs 